Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Development and Physicochemical, Toxicity and Immunogenicity Assessments of Recombinant Hepatitis B Surface Antigen (Rhbsag) Entrapped in Chitosan and Mannosylated Chitosan Nanoparticles: As a Novel Vaccine Delivery System and Adjuvant Publisher Pubmed



Mehrabi M1 ; Dounighi NM2 ; Rezayat Sorkhabadi SM1, 3 ; Doroud D4 ; Amani A1 ; Khoobi M5, 6 ; Ajdary S7 ; Pilehvarsoltanahmadi Y8
Authors

Source: Artificial Cells# Nanomedicine and Biotechnology Published:2018


Abstract

In this study chitosan nanoparticles (CS NPs) and mannosylated chitosan nanoparticles (MCH NPs) loaded with recombinant hepatitis B surface antigen (rHBsAg) was synthesized as a vaccine delivery system and assessed toxically and immunologically. The physicochemical properties of the nanoparticles (NPs) were determined by methods including scanning electron microscope (SEM) and dynamic light scattering (DLS). The morphology of the NPs was semi spherical and the average diameter of the loaded CS and MCH NPs was found to be 189 and 239 nm, respectively. The release studies showed that after the initial burst, both of the loaded NPs provided a continuous and slow release of the antigens. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed concentration and time dependent toxicity profile for both formulations, but rHBsAg loaded CS nanoparticle showed higher toxicity due to smaller particle size and larger zeta potential. Abnormal toxicity test (ATT) results showed no signs of toxicity in mice and guinea-pigs treated with loaded MCHNPs. Stability test for six months showed acceptable changes in size, surface charge, and antigenicity for loaded MCH nanoparticles. Finally, in vivo immunogenicity study revealed greater adjuvant capability of MCH nanoparticles than others formulations. Our results showed MCH NPs can be used as a controlled and targeted vaccine delivery system. © 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Development and Optimisation of Hepatitis B Recombinant Antigen Loaded Chitosan Nanoparticles As an Adjuvant Using the Response Surface Methodology, Micro and Nano Letters (2020)
2. Novel Approach to Improve Vaccine Immunogenicity: Mannosylated Chitosan Nanoparticles Loaded With Recombinant Hepatitis B Antigen As a Targeted Vaccine Delivery System, Journal of Drug Delivery Science and Technology (2018)
3. Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021), Current Pharmaceutical Biotechnology (2023)
Experts (# of related papers)
View all Related Experts
Seyed Mahdi Rezayat Sorkhabadi (3)
Mehdi Shafee Ardestani (3)
Other Related Docs
4. Macrophage Repolarization Using Cd44-Targeting Hyaluronic Acid–Polylactide Nanoparticles Containing Curcumin, Artificial Cells# Nanomedicine and Biotechnology (2018)
5. An Update on Nanoparticle-Based Contrast Agents in Medical Imaging, Artificial Cells# Nanomedicine and Biotechnology (2018)
6. Development and Characteristics of Novel Plga-Chitosan As a New Nano-Carrier for Pentavalent Vaccine Delivery, Current Pharmaceutical Biotechnology (2021)
7. Chitosan-Based Materials and Strategies in Immunotherapy and Synergistic Immunochemotherapy: A Focus on Gene-Based Immunoregulation and Car-T and Adoptive Cell Transfer, Carbohydrate Polymer Technologies and Applications (2025)
8. Inhibiting Influenza Virus Replication and Inducing Protection Against Lethal Influenza Virus Challenge Through Chitosan Nanoparticles Loaded by Sirna, Drug Delivery and Translational Research (2018)
9. Fast Antibody Responses by Immuno-Targeting and Nanotechnology Strategies Versus Hbsag Vaccine, Iranian Journal of Basic Medical Sciences (2021)
10. Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review, Biotechnology Letters (2023)
11. Multimodal Chitosan-Based Materials for Combination Immunotherapy in Cancers: Structural Engineering, Immune Regulatory Mechanisms and Synergistic Therapeutic Applications, Carbohydrate Polymers (2025)
12. Preparation and Optimization of N-Trimethyl-O-Carboxymethyl Chitosan Nanoparticles for Delivery of Low-Molecular-Weight Heparin, Pharmaceutical Development and Technology (2016)
13. Potential of Chitosan/Alginate Nanoparticles As a Non-Viral Vector for Gene Delivery: Formulation and Optimization Using D-Optimal Design, Materials Science and Engineering C (2021)
14. Evaluation of Antimicrobial Activity of Thiolated Methylated N-(4-N,N-Dimethylaminobenzyl) Chitosan As a New Derivative of Chitosan, Letters in Applied Microbiology (2022)
15. Carboxymethyl Chitosan Bounded Iron Oxide Nanoparticles and Gamma-Irradiated Avian Influenza Subtype H9n2 Vaccine to Development of Immunity on Mouse and Chicken, Veterinary Medicine and Science (2022)
16. Biosynthesis of Senps by Mycobacterium Bovis and Their Enhancing Effect on the Immune Response Against Hbs Antigens: An in Vivo Study, IET Nanobiotechnology (2018)
17. Hbs Antigen and Mannose Loading on the Surface of Iron Oxide Nanoparticles in Order to Immuno-Targeting: Fabrication, Characterization, Cellular and Humoral Immunoassay, Artificial Cells# Nanomedicine and Biotechnology (2019)
18. Simultaneous Formulation of Influenza Vaccine and Chitosan Nanoparticles Within Cpg Oligodesoxi Nucleotides Leads to Dose-Sparing and Protects Against Lethal Challenge in the Mouse Model, Pathogens and Disease (2018)
19. Synthesis of Novel Nano-Radiotracer for In-Vivo Molecular Spect Imaging: Nanosize Chitosan and Its Conjugation With Glutamine, Arabian Journal of Chemistry (2023)
20. A Review Study About the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania From 2010 to 2020, Current Drug Delivery (2021)